Earnings Scheduled For February 29, 2024
Portfolio Pulse from Benzinga Insights
Numerous companies are scheduled to report their earnings on February 29, 2024, covering a wide range of industries from technology to healthcare. This includes both expected quarterly profits and losses, with significant revenues anticipated for some. The diversity of sectors represented, from energy to financial services, highlights the broad economic implications of these reports.
February 29, 2024 | 10:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Verona Pharma is projected to report a quarterly loss of $0.26 per share on revenue of $0.
Reporting a loss with no revenue indicates financial challenges for Verona Pharma, likely leading to a negative short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80
NEUTRAL IMPACT
Frontline is expected to report quarterly earnings of $0.46 per share on revenue of $276.19 million.
Frontline's earnings report is closely watched due to its impact on the shipping industry. The expected earnings are significant but without a comparison to previous performance or market expectations, the short-term impact is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
iHuman is estimated to report earnings for its fourth quarter.
iHuman's Q4 earnings announcement is anticipated, but without specific earnings projections, the impact on its stock remains neutral in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
NB Bancorp is likely to report earnings for its Fiscal Year 2023.
NB Bancorp's fiscal year earnings will provide insights into its annual performance, but without specific figures or market expectations, the short-term stock impact remains neutral.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70